Inhibitory Checkpoint Receptor TIM-3 as a Regulator of the Functional Activity of Dendritic Cells
Authors:
- 1 July 2024
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 177 (3) , 287-292
Abstract
T-cell immunoglobulin and mucin domain 3 (TIM-3) belongs to the group of inhibitory checkpoint receptors and has traditionally been of interest in terms ofKeywords
This publication has 20 references indexed in Scilit:
- The multifunctional protein HMGB1: 50 years of discoveryNature Reviews Immunology, 2023
- TIM-3 increases the abundance of type-2 dendritic cells during Leishmania donovani infection by enhancing IL-10 production via STAT3Cell Death & Disease, 2023
- The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptakeImmunity, 2021
- Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunityCell Death & Disease, 2020
- TIM3 comes of age as an inhibitory receptorNature Reviews Immunology, 2019
- TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast CancerCancer Cell, 2018
- Review of Mouse and Human Dendritic Cell Subsets2016
- Profiling of primary peripheral blood‐ and monocyte‐derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, AustraliaClinical & Translational Immunology, 2015
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustionNature, 2014
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012